Impedimed Ltd (OTCPK:IPDQF)
$ 0.0323 0 (0%) Market Cap: 66.95 Mil Enterprise Value: 52.28 Mil PE Ratio: 0 PB Ratio: 2.65 GF Score: 0/100

Q3 2022 ImpediMed Ltd Activities Report Call Transcript

Apr 27, 2022 / 11:15PM GMT
Release Date Price: $0.0936
Operator

Thank you for standing by, and welcome to the ImpediMed Limited Quarterly Results and Investor Conference Call. (Operator Instructions)

I would now like to hand the conference over to Mr. Richard Carreon, CEO and Managing Director. Please go ahead.

Richard Carreon
ImpediMed Limited - MD, CEO, President & Executive Director

Thank you, Travis. Welcome, everyone, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending 31 March of 2022. Joining us on the call today is Tim Cruickshank, our Chief Financial Officer; and Mike Bassett, our Senior Vice President of Corporate and Strategic Development. I'll be referencing the 4C when speaking from the quarterly activity report we lodged this morning Australian time. This presentation is a summary of the more detailed 4C. After our remarks, I'll be taking questions.

Let's begin on Page 3. Today, we'll be covering 3 key topics: First, the continued momentum and ongoing strength of our business, even as the health care industry yet

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot